FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094643780> ?p ?o ?g. }

• W3094643780 endingPage "348" @default.
• W3094643780 startingPage "336" @default.
• W3094643780 abstract "Insulin resistance promotes the occurrence of liver cancer and decreases its chemosensitivity. Rosiglitazone (ROSI), a thiazolidinedione insulin sensitiser, could be used for diabetes with insulin resistance and has been reported to show anticancer effects on human malignant cells. In this paper, we investigated the combination of ROSI and chemotherapeutics on the growth and metastasis of insulin-resistant hepatoma. In vitro assay, ROSI significantly enhanced the inhibitory effects of adriamycin (ADR) on the proliferation, autophagy and migration of insulin-resistant hepatoma HepG2/IR cells via downregulation of EGFR/ERK and AKT/mTOR signalling pathway. In addition, ROSI promoted the apoptosis of HepG2/IR cells induced by ADR. In vivo assay, high fat and glucose diet and streptozotocin (STZ) induced insulin resistance in mice by increasing the body weight, fasting blood glucose (FBG) level, oral glucose tolerance, fasting insulin level and insulin resistance index. Both the growth of mouse liver cancer hepatoma H22 cells and serum FBG level in insulin resistant mice were significantly inhibited by combination of ROSI and ADR. Thus, ROSI and ADR in combination showed a stronger anti-tumour effect in insulin resistant hepatoma cells accompanying with glucose reduction and might represent an effective therapeutic strategy for liver cancer accompanied with insulin resistant diabetes." @default.
• W3094643780 created "2020-11-09" @default.
• W3094643780 creator A5010115566 @default.
• W3094643780 creator A5010137160 @default.
• W3094643780 creator A5017022088 @default.
• W3094643780 creator A5019966763 @default.
• W3094643780 creator A5040473320 @default.
• W3094643780 creator A5040796317 @default.
• W3094643780 creator A5051984141 @default.
• W3094643780 date "2021-01-18" @default.
• W3094643780 modified "2023-09-25" @default.
• W3094643780 title "Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer" @default.
• W3094643780 cites W1581731557 @default.
• W3094643780 cites W1928661409 @default.
• W3094643780 cites W1981576729 @default.
• W3094643780 cites W2026986256 @default.
• W3094643780 cites W2032440336 @default.
• W3094643780 cites W2032661288 @default.
• W3094643780 cites W2036868154 @default.
• W3094643780 cites W2065417819 @default.
• W3094643780 cites W2074433596 @default.
• W3094643780 cites W2118025220 @default.
• W3094643780 cites W2118456958 @default.
• W3094643780 cites W2136308565 @default.
• W3094643780 cites W2149943622 @default.
• W3094643780 cites W2159501405 @default.
• W3094643780 cites W2170240687 @default.
• W3094643780 cites W2283163602 @default.
• W3094643780 cites W2327801363 @default.
• W3094643780 cites W2460290768 @default.
• W3094643780 cites W2491734341 @default.
• W3094643780 cites W2698793465 @default.
• W3094643780 cites W2720177151 @default.
• W3094643780 cites W2769931812 @default.
• W3094643780 cites W2772389815 @default.
• W3094643780 cites W2773951840 @default.
• W3094643780 cites W2789170446 @default.
• W3094643780 cites W2799487692 @default.
• W3094643780 cites W2809658305 @default.
• W3094643780 cites W2819055586 @default.
• W3094643780 cites W2885439869 @default.
• W3094643780 cites W2898649522 @default.
• W3094643780 cites W2901033390 @default.
• W3094643780 cites W2905659470 @default.
• W3094643780 cites W2910344062 @default.
• W3094643780 cites W2914626105 @default.
• W3094643780 doi "https://doi.org/10.1080/1061186x.2020.1844216" @default.
• W3094643780 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33115283" @default.
• W3094643780 hasPublicationYear "2021" @default.
• W3094643780 type Work @default.
• W3094643780 sameAs 3094643780 @default.
• W3094643780 citedByCount "4" @default.
• W3094643780 countsByYear W30946437802022 @default.
• W3094643780 countsByYear W30946437802023 @default.
• W3094643780 crossrefType "journal-article" @default.
• W3094643780 hasAuthorship W3094643780A5010115566 @default.
• W3094643780 hasAuthorship W3094643780A5010137160 @default.
• W3094643780 hasAuthorship W3094643780A5017022088 @default.
• W3094643780 hasAuthorship W3094643780A5019966763 @default.
• W3094643780 hasAuthorship W3094643780A5040473320 @default.
• W3094643780 hasAuthorship W3094643780A5040796317 @default.
• W3094643780 hasAuthorship W3094643780A5051984141 @default.
• W3094643780 hasConcept C104317684 @default.
• W3094643780 hasConcept C126322002 @default.
• W3094643780 hasConcept C127561419 @default.
• W3094643780 hasConcept C134018914 @default.
• W3094643780 hasConcept C190283241 @default.
• W3094643780 hasConcept C2776923340 @default.
• W3094643780 hasConcept C2777180221 @default.
• W3094643780 hasConcept C2777391703 @default.
• W3094643780 hasConcept C2779306644 @default.
• W3094643780 hasConcept C2780152017 @default.
• W3094643780 hasConcept C55493867 @default.
• W3094643780 hasConcept C555293320 @default.
• W3094643780 hasConcept C71924100 @default.
• W3094643780 hasConcept C86554907 @default.
• W3094643780 hasConcept C86803240 @default.
• W3094643780 hasConceptScore W3094643780C104317684 @default.
• W3094643780 hasConceptScore W3094643780C126322002 @default.
• W3094643780 hasConceptScore W3094643780C127561419 @default.
• W3094643780 hasConceptScore W3094643780C134018914 @default.
• W3094643780 hasConceptScore W3094643780C190283241 @default.
• W3094643780 hasConceptScore W3094643780C2776923340 @default.
• W3094643780 hasConceptScore W3094643780C2777180221 @default.
• W3094643780 hasConceptScore W3094643780C2777391703 @default.
• W3094643780 hasConceptScore W3094643780C2779306644 @default.
• W3094643780 hasConceptScore W3094643780C2780152017 @default.
• W3094643780 hasConceptScore W3094643780C55493867 @default.
• W3094643780 hasConceptScore W3094643780C555293320 @default.
• W3094643780 hasConceptScore W3094643780C71924100 @default.
• W3094643780 hasConceptScore W3094643780C86554907 @default.
• W3094643780 hasConceptScore W3094643780C86803240 @default.
• W3094643780 hasFunder F4320324174 @default.
• W3094643780 hasFunder F4320333596 @default.
• W3094643780 hasIssue "3" @default.
• W3094643780 hasLocation W30946437801 @default.
• W3094643780 hasLocation W30946437802 @default.
• W3094643780 hasOpenAccess W3094643780 @default.

• next